RCKT
Rocket Pharmaceuticals Inc
NASDAQ: RCKT · HEALTHCARE · BIOTECHNOLOGY
$3.48
+0.00% today
Updated 2026-04-30
Market cap
$379.93M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.01
Dividend yield
—
52W range
$2 – $8
Volume
3.7M
Rocket Pharmaceuticals Inc (RCKT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.42M | $12.86M | $5.52M | $113.32M | $129.65M | $101.78M | $251.31M | $372.12M | $590.82M | $497.02M | $551.81M | $566.34M | $527.70M |
| Cash & equivalents | $1.37M | $12.79M | $3.62M | $80.04M | $29.80M | $78.72M | $111.36M | $185.38M | $297.10M | $232.69M | $140.52M | $55.90M | $163.63M |
| Current assets | $1.42M | $12.86M | $3.62M | $112.37M | $128.35M | $101.05M | $209.09M | $307.75M | $487.35M | $392.06M | $364.06M | $378.22M | $378.18M |
| Total liabilities | $32.35M | $51.76M | $57.08M | $4.51M | $56.48M | $54.01M | $57.28M | $64.82M | $87.31M | $42.30M | $62.12M | $73.77M | $64.47M |
| Current liabilities | $3.77M | $3.22M | $3.70M | $4.14M | $7.21M | $4.07M | $15.37M | $18.31M | $32.62M | $22.17M | $39.17M | $48.51M | $40.68M |
| Long-term debt | — | — | $2.55M | $0.00 | $48.96M | $49.54M | $41.45M | $45.05M | $35.07M | — | — | — | — |
| Shareholder equity | $-30.93M | $-38.90M | $-51.56M | $108.81M | $73.17M | $47.76M | $194.04M | $307.30M | $503.52M | $454.72M | $489.69M | $492.57M | $463.23M |
| Retained earnings | $-110.89M | $-118.51M | $-128.04M | $-196.02M | $-238.88M | $-268.37M | $-105.87M | $-183.14M | $-322.84M | $-491.91M | $-713.77M | $-959.37M | $-1.22B |
| Accounts receivable | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Goodwill | — | — | — | $0.00 | $0.00 | $0.00 | $30.82M | $30.82M | $30.82M | $30.82M | $39.15M | $39.15M | $39.15M |